Outlook Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants
OTLK•Proposed public offering and use of proceeds
Aug. 12 (Reuters) - Outlook Therapeutics Inc. OTLK.O:
- Outlook Therapeutics announces a proposed public offering of common stock and warrants.
- Proceeds are expected to support the LYTENAVA U.S. launch, working capital, and corporate purposes.
